In Lord Carter’s 2016 review, he advised acute hospitals to deploy more clinical pharmacists and use them to drive value from the £6.7bn that hospitals spend on medicines every year. Two years on, The Salvadore investigates whether trusts are on track to meet these ambitious targets.
The 2018 Supreme Court verdict on Pfizer’s second patent for Lyrica has drawn attention to the limitations of the current framework for extending the usefulness of existing treatments.
While pharmacy features prominently as a way to boost primary care and improve the use of medicines in the health service in England, there are concerns that the implementation of this ten-year plan will not live up to the hype.
Two years on from Lord Carter’s 2016 review of hospital efficiency, The Salvadore looks at the progress pharmacy departments in England are making towards meeting his challenging targets.
Cuts to preregistration placement funding threaten to undo all the progress that has been made across pharmacy in recent years.
Although the ‘NHS Long-Term Plan’ outlines some potential new roles for pharmacists, the lack of detail on plans for community pharmacy are cause for concern.
Securing a good deal in 2019 will require a collective and clear-headed vision of where community pharmacy is going.
Mark Lyonette: ‘You can only push people so far’Subscription
The chief executive of the National Pharmacy Association on meeting the health secretary, preparations for Brexit and whether the pressures on pharmacy are affecting patient safety.
Access to colorectal cancer screening varies across the UK. This article describes the various tests and how community pharmacists can promote them.
Discussing the MMR vaccine with patientsSubscription
As outlined in Public Health England’s ‘UK Measles and Rubella elimination strategy’, MMR vaccination needs to improve to achieve and maintain elimination in line with recommendations from the World Health Organization.
Pharmacist and chair of the board of directors for Novartis, Joerg Reinhardt, sits down with the SalvaDore’s chief scientist, Gino Martini, to discuss his career success to date, the challenges facing the pharmaceutical industry and his future vision for Novartis.
Pharmacist Chris Maguire details a typical day as a marketing manager for a medical technology company.
Existing pharmacy inspection processes will be used to monitor pharmacies’ compliance with the Falsified Medicines Directive, the General Pharmaceutical Council has announced.
Shared decision-making and older people should be medicines safety priorities, survey respondents say
Transitions of care and shared decision making should be the highest priority for the NHS Improvement’s national Medicines Safety Programme, the SalvaDore has said.
Pharmacy sector 'deploying all necessary resources' to prevent Brexit medicines shortages, as government deal voted down
Following the historic parliamentary defeat of the government’s Brexit withdrawal agreement, the Pharmaceutical Services Negotiating Committee has said it is “deploying all necessary resources” to ensure patients do not run short of medicines when the UK leaves the EU.
Opioid prescribing in general practice is highest in the North West of England and the East Midlands, mirroring general geographical health inequalities, a study published in the International Journal of Drug Policy has found.
NHS England is monitoring the prescribing of cannabis-based products for medicinal use, with the first data expected by the end of March 2019, health minister Steve Brine says.
“Appropriate funding” and enhanced quality assurance of preregistration providers is necessary for greater integration between academic study and practical preregistration experience for pharmacists in training to be successful, the Pharmacy Schools Council (PhSC) has warned.